Ashish K. Khanna

A​shish K.Khanna, MD, FCCP, FCCM, is a staff intensivist & anesthesiologist, Associate Professor of Anesthesiology and Associate Chief for Research with the Department of Anesthesiology, section on critical care medicine at the Wake Forest University School of Medicine, Winston-Salem, NC. Dr.Khanna is the immediate past ​chair of the Society of Critical Care Medicine’s (SCCM) In-Training Section and a current outgoing chair for the SCCM Postgraduate and Fellowship Education Committee. He is a recent recipient of the SCCM presidential citation for the years 2016, 2017 & 2019 and a successful nominee as a​ fellow of the American College of Critical Care Medicine (FCCM) in 2018. He is also a part of the SCCM program planning committee (term until 2022), the SCCM Discovery Research Network Steering Committee (term until 2022), the THRIVE ICU survivors task force and the adult item writing committee (term until 2021). As part of the SCCM Anesthesiology section for the last six years, and a current member of the Anesthesiology section Steering Committee and communications sub-committee, he has been extensively involved with the Anesthesiology year-in-review program at SCCM, has presented as faculty, and continues to do the same. Other SCCM faculty presence includes, the conception, design and moderation of the SCCM Critical Care Quiz Show, and Critical Crosstalk sessions, the fellowship program directors’ luncheon and the ‘transitioning to attending’ programs lead by the in-training section. He has authored extensively for Critical Connections – the official newsletter for the society. Dr.Khanna is also vice-chair for the American Society of Anesthesiologists (ASA) committee on critical care medicine and abstract review committee on critical care medicine. He has completed six years with the educational track sub-committee on critical care medicine for the ASA. He is part of the Society of Critical Care Anesthesiologists (SOCCA) committee on education. His research interests include, prediction of post-operative respiratory and cardiac events on the regular nursing floor, outcomes of hypotension in critically ill patients and use of novel vasopressors in shock states in the ICU. From 2015-2017 Dr.Khanna was the lead investigator for the Angiotensin II in High Output Shock (ATHOS-3) trial, that was subsequently published in the NEJM in the summer of 2017. He also recently lead and completed the Prediction of Opioid Induced Respiratory Depression in Patients Monitored by Capnography (PRODIGY) trial in 16 sites across the world.